0001529349-19-000001.txt : 20190207 0001529349-19-000001.hdr.sgml : 20190207 20190206180611 ACCESSION NUMBER: 0001529349-19-000001 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20190207 DATE AS OF CHANGE: 20190206 EFFECTIVENESS DATE: 20190207 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Abrexa Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001529349 IRS NUMBER: 453074039 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-318790 FILM NUMBER: 19572969 BUSINESS ADDRESS: STREET 1: 1282 UPAS STREET CITY: SAN DIEGO STATE: CA ZIP: 92103 BUSINESS PHONE: (619) 295-5077 MAIL ADDRESS: STREET 1: 1282 UPAS STREET CITY: SAN DIEGO STATE: CA ZIP: 92103 D/A 1 primary_doc.xml X0708 D/A LIVE 0001529349 Abrexa Pharmaceuticals, Inc. 1282 UPAS STREET SAN DIEGO CA CALIFORNIA 92103 (619) 295-5077 DELAWARE None None Corporation true J. Ernest Villafranca 1282 Upas Street San Diego CA CALIFORNIA 92103 Executive Officer Director James J. Truchard 1282 Upas Street San Diego CA CALIFORNIA 92103 Director David Hugley 1282 Upas Street San Diego CA CALIFORNIA 92103 Director Other Health Care Decline to Disclose 06b true 0001529349-18-000003 2018-07-25 false true false 0 16632252 16632252 0 false 7 0 0 180000 true false Abrexa Pharmaceuticals, Inc. J. Ernest Villafranca J. Ernest Villafranca Chief Executive Officer 2019-02-04